Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)
曲妥珠单抗-美坦新治疗 HER2 阳性转移性乳腺癌的临床获益:日本一项真实世界多中心队列研究 (WJOG12519B)
期刊:Breast Cancer
影响因子:2.9
doi:10.1007/s12282-020-01192-y
Yokoe, Takamichi; Kurozumi, Sasagu; Nozawa, Kazuki; Ozaki, Yukinori; Maeda, Tetsuyo; Yazaki, Shu; Onishi, Mai; Fujimoto, Akihiro; Nakayama, Sayuka; Tsuboguchi, Yuko; Iwasa, Tsutomu; Sakai, Hitomi; Ogata, Misato; Terada, Mitsuo; Nishimura, Meiko; Onoe, Takuma; Masuda, Jun; Kurikawa, Michiko; Isaka, Hirotsugu; Hagio, Kanako; Shimomura, Akihiko; Okumura, Yuta; Futamura, Manabu; Shimokawa, Mototsugu; Takano, Toshimi